Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration.

@article{Tibau2016OncologicDA,
  title={Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration.},
  author={Ariadna Tibau and Alberto Oca{\~n}a and Ge{\`o}rgia Anguera and Bo{\vs}tjan {\vS}eruga and Arnoud J Templeton and Agust{\'i} Barnadas and Eitan Amir},
  journal={JAMA oncology},
  year={2016},
  volume={2 6},
  pages={744-50}
}
IMPORTANCE The US Food and Drug Administration (FDA) advisory committees influence decisions relating to the regulatory approval of drugs in the United States. Outside of the field of oncology, prosponsor voting bias has been observed among members with financial conflicts of interest (FCOIs). OBJECTIVE To explore factors associated with Oncologic Drugs Advisory Committee (ODAC) recommendations and the influence ODAC members' FCOIs on the drug approval process. DESIGN, SETTING, AND… CONTINUE READING